Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-015024
Filing Date
2021-06-22
Accepted
2021-06-22 17:25:38
Documents
1
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 9661
  Complete submission text file 0001493152-21-015024.txt   11326
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000315545 (see all company filings)

EIN.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address
Bailey Webster (Reporting) CIK: 0001818267 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36457 | Film No.: 211036360